RAFAEL HOLDINGS, INC. Financing Interest Expense
RAFAEL HOLDINGS, INC. (RFL) reported Financing Interest Expense of $20.09 thousand for the 3-month period ending 2021-10-31, per its 10-Q/A filed 2022-02-28.
Discontinued › Expense Statement › Interest Expense
us-gaap:FinancingInterestExpense · last filed 2022-06-14
- RAFAEL HOLDINGS, INC. financing interest expense for the quarter ending 2021-10-31 was $20.09K.
- RAFAEL HOLDINGS, INC. financing interest expense for fiscal 2021 was $10.29K.
| Period end | Financing Interest Expense 1 month | Financing Interest Expense 3 month | Financing Interest Expense 12 month |
|---|---|---|---|
| 2021-10-31 | $20.09K 10-Q · filed 2022-06-14 | $20.09K 10-Q/A · filed 2022-02-28 | |
| 2021-07-31 | $10.29K 10-K · filed 2021-10-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |